Differences between randomized clinical trial participants and real-world empagliflozin users and the changes in their glycated hemoglobin levels

Nicolai E. Munk, Jakob S. Knudsen, Anton Pottegard, Daniel R. Witte, Reimar W. Thomsen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number4342
JournalPharmacoepidemiology and Drug Safety
Volume29
Issue numberSuppl. 3
Pages (from-to)129-130
ISSN1053-8569
Publication statusPublished - 1. Oct 2020
Event36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management -
Duration: 16. Sep 202017. Sep 2020

Conference

Conference36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Period16/09/202017/09/2020

Cite this